Moving Toward Transparency of Clinical Trials
- 7 March 2008
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 319 (5868), 1340-1342
- https://doi.org/10.1126/science.1153632
Abstract
As new policies promote transparency of clinical trials through registries and results databases, further issues arise and require examination.This publication has 33 references indexed in Scilit:
- Selective Publication of Antidepressant Trials and Its Influence on Apparent EfficacyThe New England Journal of Medicine, 2008
- Publication bias against negative results from clinical trials: three of the seven deadly sinsNature Clinical Practice Neurology, 2007
- The Rosiglitazone Story — Lessons from an FDA Advisory Committee MeetingThe New England Journal of Medicine, 2007
- Governmental influences on drug development: striking a better balanceNature Reviews Drug Discovery, 2007
- What have we learnt from Vioxx?BMJ, 2007
- Publishing Clinical Trial Results: The Future BeckonsPLoS Clinical Trials, 2006
- Learning from the TGN1412 trialBMJ, 2006
- Clinical Trials Results Databases: Unanswered QuestionsScience, 2006
- Lessons From the Failure and Recall of an Implantable Cardioverter-DefibrillatorCirculation, 2005
- FDA Weighs Suicide Risk in Children on AntidepressantsScience, 2004